J&J agrees to pay $785M for surgery tech firm

Johnson & Johnson, in the latest of a string of significant deals this year, said it would pay $785 million in cash to acquire privately held Acclarent and its sinus-surgery technology. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.